Combination creates a global in vitro diagnostics company with brand identity and a strong financial profile Initial full year expectations for over $150 million in revenue, strong EBITDA and positive cash flow Transaction expected to be substantially accretive to Nanogen 2009 earnings per share SAN DIEGO & PARIS–Nanogen, Inc. (NASDAQ: NGEN), developer of molecular and […]
MUKILTEO, Wash., Aug. 12, 2008 (PRIME NEWSWIRE) — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that a retrospective, clinical validation study of its test for Chronic Lymphocytic Leukemia (CLL) is to be published in the September issue of the Journal of Molecular Diagnostics (J Mol Diagn 2008, 10:442-451). This publication augments an earlier publication in […]
Embarks on Joint Public Awareness Campaign, Provides Financial Support to Mia Hamm Foundation CAMBRIDGE, Mass.–ViaCord, a wholly-owned subsidiary of PerkinElmer, Inc. (NYSE: PKI – News), today announced a new partnership with global sports superstar Mia Hamm and the Mia Hamm Foundation to jointly raise awareness of the value and benefits of umbilical cord blood banking, […]
Companies Establish Key Partnership for Validation and Commercialization Purposes WILMINGTON, NC, Aug 11, 2008 — Gene Express, Inc. today announced that it has signed three definitive agreements with NeoGenomics Laboratories to license the SEM Center and StaRT-PCR(TM) (Standardized Reverse Transcription Polymerase Chain Reaction) Technology. NeoGenomics will support Gene Express in its FDA validation of its […]
MUKILTEO, Wash., Aug. 6, 2008 (PRIME NEWSWIRE) — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that renowned cancer expert, Colin Collins, Ph.D., has joined the Scientific Advisory Board (SAB) of its subsidiary reference laboratory Combimatrix Molecular Diagnostics (CMDX). Dr. Collins is an Associate Professor of Urology at the Cancer Research Institute and Department of Laboratory […]
ROCKVILLE, Md.–Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical and biodefense markets, today announced the expansion of its Scientific Advisory Board. “We are pleased to announce the addition of Dr. Barry Kreiswirth and Dr. Gary Procop to IBI’s diagnostic focused Scientific Advisory Board,” said Joe […]
Venlo, The Netherlands, August 4, 2008 – New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommend testing women 30 and over for HPV (human papillomavirus) — the primary cause of cervical cancer. The guidelines recommend that HPV testing be performed along with a Pap smear for women 30 […]
Pathwork(R) Tissue of Origin Test is the First Gene Expression Microarray-Based Test to Receive Clearance SANTA CLARA, Calif.–Affymetrix Inc. (Nasdaq:AFFX – News) announced today that the U.S. Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The microarray system was granted clearance along […]
Agencourt Genfind? System for DNA Isolation to be Integrated into HPV Test Development FULLERTON, Calif. (July 30, 2008) – Agencourt Bioscience, a wholly owned subsidiary of Beckman Coulter, Inc., today announced that it has entered into a supply agreement with Madison, Wisconsin-based Third Wave Technologies, Inc., a wholly owned subsidiary of Hologic, Inc. Under the […]
SAN DIEGO & ANN ARBOR, Mich.–Sequenom, Inc. (NASDAQ: SQNM – News), a leading provider of molecular diagnostic applications and genetic analysis products and services, and SensiGen LLC, a privately held biotechnology company focused on developing proprietary gene-based, molecular diagnostic tests, today announced expansion of their global alliance to develop and market advanced diagnostic tests and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
